Mattia Galli: Waiting for “Better Evidence” May Delay Better Treatment for Patients
Mattia Galli, Assistant Professor at Sapienza University of Rome, Associate Editor of European Heart Journal, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Of the more than 50 study-level meta-analyses I have published, can you guess how many have been proven wrong or inaccurate by subsequent RCTs or IPD meta-analyses?
NONE.
I could provide dozens of examples, but the most emblematic is our meta-analysis published in The Lancet in 2021.
Five years later, we published an IPD meta-analysis demonstrating EXACTLY the same results.
The figures were even presented in the same format — deliberately so (see below).
That is five years spent waiting for ‘better evidence.’ Five years during which patients could have received better treatment.
Now that guidelines will finally need to align with these findings, I hope this case might inspire future guideline committees to reflect.”
Title: Genotype-Guided vs Conventional Oral P2Y12 Inhibitors in Acute Coronary Syndrome: A Combined Analysis of TAILOR-PCI and POPular Genetics
Authors: Mattia Galli, Naveen L. Pereira, Ryan J. Lennon, Wout W.A. van den Broek, Daniel M.F. Claassens, Thomas O. Bergmeijer, Yves Rosenberg, Luca Fazzini, Vera H.M. Deneer, M. Hassan Murad, Michael E. Farkouh, Charanjit Rihal, Jurrien ten Berg, Dominick J. Angiolillo
Read the Full Article on JACC: Cardiovascular Interventions
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 10, 2026, 09:31Help Shape the New ASH Iron Deficiency Guidelines – American Society of Hematology
-
Oct 10, 2026, 09:05Wolfgang Miesbach: Moving from Bleed Control to Comprehensive Joint Health
-
Oct 10, 2026, 07:59Leila Caroline Souza Reis: Enoxaparin Dosing for VTE Prevention in Adults With Obesity
-
Oct 10, 2026, 07:41Adeeb Bazuhair: New Evidence for Catheter Directed Thrombolysis in Acute PE
-
Oct 10, 2026, 07:22Poppy Clarke: Turning Steps Into Support for Thrombosis Awareness
-
Oct 10, 2026, 07:12Hamzah Khan: The Role of Genuine Curiosity in Driving High-Impact Academic Research
-
Oct 10, 2026, 06:58Nita Radhakrishnan: Turning Evidence Into Action for Hemophilia Care in India
-
Oct 10, 2026, 06:48Nutan Kaushik: HemeNext 2.0 Brings Global Perspectives to Hematology
-
Oct 10, 2026, 06:43Suthesh Sivapalaratnam: Advancing Bleeding Disorder Care at EHC 2026